Search research articles
Contact Us
Filters
Showing results (21-30 of 180) with videos related to
Page
of 18
Sort By:
Toxicology
|
March 1, 1987
Alkylformamides as inducers of tumour cell differentiation--a mini-review
S P Langdon, J A Hickman
Journal of Cognitive Neuroscience
|
August 22, 2013
Learning and maintaining saccadic accuracy: a model of brainstem-cerebellar interactions
P Dean, J E Mayhew, P Langdon
Onkologie
|
November 6, 2009
The importance of growth factors and steroid hormones in ovarian cancer
Simon P Langdon, Dana Faratian, David J Harrison
Methods in Molecular Medicine
|
February 23, 2011
Ovarian cancer models : technical review
S P Langdon, J Edwards, J M Bartlett
Breast (Edinburgh, Scotland)
|
October 3, 2015
Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow
Ian H Kunkler, Carol Ward, Simon P Langdon
Discovery Medicine
|
October 1, 2009
How can systems pathology help us personalize cancer therapy?
Dana Faratian, Simon P Langdon, David J Harrison
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1997
Endothelin expression and responsiveness in human ovarian carcinoma cell lines
S Moraitis, S P Langdon, W R Miller
Leukemia Research
|
January 1, 1988
Investigations of the relationship between cell proliferation and differentiation of HL-60 cells induced to differentiate by N-methylformamide
S P Langdon, F M Richards, J A Hickman
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
Sarah J Taylor, Mark J Arends, Simon P Langdon
Experimental Cell Research
|
February 15, 2005
Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration
Jane M Sewell, John F Smyth, Simon P Langdon
Page
of 18
Search research articles
Search
Showing results (21-30 of 180) with videos related to
Sort By:
Page
of 18
Toxicology
|
March 1, 1987
Alkylformamides as inducers of tumour cell differentiation--a mini-review
S P Langdon, J A Hickman
Journal of Cognitive Neuroscience
|
August 22, 2013
Learning and maintaining saccadic accuracy: a model of brainstem-cerebellar interactions
P Dean, J E Mayhew, P Langdon
Onkologie
|
November 6, 2009
The importance of growth factors and steroid hormones in ovarian cancer
Simon P Langdon, Dana Faratian, David J Harrison
Methods in Molecular Medicine
|
February 23, 2011
Ovarian cancer models : technical review
S P Langdon, J Edwards, J M Bartlett
Breast (Edinburgh, Scotland)
|
October 3, 2015
Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow
Ian H Kunkler, Carol Ward, Simon P Langdon
Discovery Medicine
|
October 1, 2009
How can systems pathology help us personalize cancer therapy?
Dana Faratian, Simon P Langdon, David J Harrison
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1997
Endothelin expression and responsiveness in human ovarian carcinoma cell lines
S Moraitis, S P Langdon, W R Miller
Leukemia Research
|
January 1, 1988
Investigations of the relationship between cell proliferation and differentiation of HL-60 cells induced to differentiate by N-methylformamide
S P Langdon, F M Richards, J A Hickman
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
Sarah J Taylor, Mark J Arends, Simon P Langdon
Experimental Cell Research
|
February 15, 2005
Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration
Jane M Sewell, John F Smyth, Simon P Langdon
Page
of 18